Q4 2025 Management View CEO Lawrence Firestone presented 2025 as a transition year, emphasizing the closure of legacy business issues, reduction in manufacturing overhead, and the payoff of all ...
The consensus estimate for Q4 2025 revenue is $4.10 million, and the earnings are expected to come in at -$7.35 per share.
Meet 22nd Century Group, the biotech co. driven by the mission to reduce the harm caused by smoking.
Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.
Q4 net revenues decreased slightly to $3.5 million from $4.0 million in Q3 2025, and misses by $0.55M. GAAP EPS of -$5.89. Net loss was $2.8 million, compared to net loss of $3.8 million. Adjusted ...
MOCKSVILLE, N.C.,, June 26, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that is leading the fight against nicotine by offering smokers a choice ...
Q4 2025 Earnings Call March 26, 2026 8:00 AM EDTCompany ParticipantsMatthew Kreps - Investor RelationsLawrence Firestone ...
Expansion in 2026 Forecasted to Exceed 5,000 Retail Outlets Nationwide as Consumers Demonstrate Interest in VLN ® Brands VLN ® Remains the Only FDA-Authorized Combustible Cigarette Designed to Reduce ...
Despite a dip in revenue, 22nd Century Group Inc (XXII) focuses on growth with new products and regulatory advancements, ...
Detailed price information for 22nd Century Group Inc (XXII-Q) from The Globe and Mail including charting and trades.
On Monday, the company announced an agreement to fund all intellectual property, licensing and sponsored research payments to North Carolina State University through 2025 in equity as part of a deal ...
New platform empowers commercial and public-sector treasury teams to turn account balances into a revenue engine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results